Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

102 trials

Showing 20 of 102 results

Large-scale testing (Phase 3)Study completedNCT02119156
What this trial is testing

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 80
Testing effectiveness (Phase 2)Study completedNCT05154734
What this trial is testing

Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum Disorder
Tianjin Medical University General Hospital 14
Testing effectiveness (Phase 2)Ended earlyNCT04767698
What this trial is testing

Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 4
Not applicableUnknownNCT05659407
What this trial is testing

BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisBLyS Polymorphism
University of Cagliari 60
Not applicableUnknownNCT03919643
What this trial is testing

BAFF and APRIL and RESPONSE TO BELIMUMAB in SLE

Who this might be right for
Systemic Lupus ErythematosusBAFF Polymorphism
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 200
Testing effectiveness (Phase 2)Study completedNCT02124798
What this trial is testing

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 95
Post-approval studies (Phase 4)Study completedNCT04908865
What this trial is testing

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 67
Testing effectiveness (Phase 2)Study completedNCT01008982
What this trial is testing

Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
University of Udine 15
Post-approval studies (Phase 4)UnknownNCT04660565
What this trial is testing

Belimumab Treatment for IgG4-related Disease

Who this might be right for
IgG4-related Disease
Peking Union Medical College Hospital 60
Not applicableNot Yet RecruitingNCT07069972
What this trial is testing

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Yipeng Liu 180
Post-approval studies (Phase 4)Looking for participantsNCT03543839
What this trial is testing

Trial of Belimumab in Early Lupus

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus
Northwell Health 30
Testing effectiveness (Phase 2)WithdrawnNCT01440361
What this trial is testing

Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline
Not applicableStudy completedNCT01858792
What this trial is testing

A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

Who this might be right for
Lupus Erythematosus, Discoid
Human Genome Sciences Inc., a GSK Company 1
Testing effectiveness (Phase 2)Ended earlyNCT00583557
What this trial is testing

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Who this might be right for
Rheumatoid Arthritis
Human Genome Sciences Inc. 155
Testing effectiveness (Phase 2)Study completedNCT01649765
What this trial is testing

Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 93
Not applicableStudy completedNCT07031674
What this trial is testing

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Who this might be right for
Lupus NephritisBelimumab
Yipeng Liu 56
Large-scale testing (Phase 3)Study completedNCT01597622
What this trial is testing

BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 142
Testing effectiveness (Phase 2)Study completedNCT01480596
What this trial is testing

The Evaluation of Belimumab in Myasthenia Gravis (MG)

Who this might be right for
Myasthaenia Gravis
GlaxoSmithKline 40
Post-approval studies (Phase 4)Study completedNCT04515719
What this trial is testing

Efficacy and Safety of Belimumab in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
RenJi Hospital 231
Early research (Phase 1)Study completedNCT02880852
What this trial is testing

Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation